 Phase trial tissue plasminogen activator prevention vasospasm patients aneurysmal subarachnoid hemorrhage Recent laboratory studies intracisternal administration recombinant tissue plasminogen activator rt-PA normal clearing blood subarachnoid space prevent arterial spasm results preliminary Phase trial intracisternal rt-PA patients documented aneurysmal subarachnoid hemorrhage SAH patients clinical Grade III IV Hunt Hess thick clots layers blood basal cisterns major cerebral fissures Fisher Grade Ventriculostomy surgery clipping aneurysms hours hemorrhage patient mg rt-PA subarachnoid dura patients small silicone catheter subarachnoid space rt-PA mg cases mg mg hours infusions cases hours surgery Minor local bleeding complications patients mg Oozing operative incision site patients ventriculostomy site patients patient small epidural hematoma delayed drainage complications patients regimen rt-PA infusions mg Serial coagulation studies evidence systemic fibrinolysis Analysis cisternal cerebrospinal fluid samples thrombolytic tissue plasminogen activator t-PA levels hours Follow-up cerebral angiography days rupture mild spasm patients patient hemorrhage posterior inferior cerebellar artery aneurysm severe focal spasm vertebral arteries symptomatic results postoperative treatment rt-PA effective severity delayed cerebral vasospasm results serial t-PA levels dosage regimen divided dosages intervals dosages effective Further studies